{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/21/3349079/0/en/alvotech-announces-licensing-and-commercialization-agreement-with-lotus-pharmaceutical-for-proposed-biosimilars-to-durvalumab-and-emicizumab-in-the-u-s-and-selected-asian-markets.html", "message": "News view counter 896575 successfully enlarged"}